MEDI-507

A monoclonal antibody that is being studied in the treatment of certain lymphoproliferative disorders and psoriasis. Also called siplizumab.

Anticuerpo monoclonal en estudio para el tratamiento de ciertos trastornos linfoproliferativos y de la psoriasis. TambiƩn se llama siplizumab.